AllDocs -> cancers

2003 Questions about Cancer ? When you want to know more about cancer call the Canadian Cancer Society's CANCER INFORMATION SERVICE 1888 939-3333 MONDAY TO FRIDAY : 9 AM –6 PM DISTRIBUTED BY : 111-223 CanadianCancer Statistics PRODUCED BY : CANADIAN CANCER SOCIETY , NATIONAL CANCER INSTITUTE OF CANADA , STATISTICS CANADA , PROVINCIAL / TERRITORIAL CANCER REGISTRIES , HEALTH CANADA www. cancer .ca Page 2 Steering Committee Members John R. McLaughlin (Chair), Ph.D. Division of Epidemiology and Biostatistics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario Dagny Dryer, M.D., F.R.C.P.C. PEI Cancer Treatment ...

© Cancer Society of New Zealand Inc May 2003 Bowel Cancer Bowel cancer is cancer of the colon and rectum, or colorectal cancer . Each year in New Zealand about 2400 New Zealanders are diagnosed with bowel can- cer and about 1100 die from it. It is the second most common cancer registered for both men and women. What causes it? As with all cancers , there is unlikely to be a single cause. However, there are factors that may increase or decrease the risk of developing particular types of cancer . Some of these things we can do something about, some we can’t. Even if we do take action to reduce our risk, there is no guarantee we will not get cancer , but we can help reduce the chances. One of the most important factors in the development of bowel cancer seems to be the traditional western diet. Eating plenty of fruits, vegetables, breads, ...

Cancer Care Ontario Program in Evidence-based Care Practice Guidelines Initiative Sponsored by: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-Fluorouracil and Leucovorin (5FU/LV) as First-Line Therapy for Metastatic Colorectal Cancer Practice Guideline Report #2-16b ORIGINAL GUIDELINE: October 23, 2001 MOST RECENT LITERATURE SEARCH: February 19, 2003 NEW EVIDENCE ADDED TO THE GUIDELINE REPORT: February 2003 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Question What is the role of irinotecan combined with 5-fluorouracil and leucovorin as first-line systemic therapy in the management of metastatic colorectal cancer ? The primary endpoint of interest ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored by: Cancer Care Ontario & the Ontario Ministry of Health and Long-Term Care Use of Raltitrexed (Tomudex) in the Management of Metastatic Colorectal Cancer Practice Guideline Report #2-17 ORIGINAL GUIDELINE: May 22, 1998 MOST RECENT LITERATURE SEARCH: February 21, 2003 NEW EVIDENCE ADDED TO THE GUIDELINE REPORT: July, 2002 New evidence found by the update searches since completion of the original guideline is consistent with the original recommendations. Guideline Question What is the role of raltitrexed (Tomudex) in the management of metastatic colorectal cancer ? Target Population These recommendations apply to adult patients with metastatic colorectal cancer for whom chemotherapy is indicated. Recommendations • For patients with previously untreated metastatic ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored by: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care Concomitant Chemotherapy and Radiotherapy in Squamous Cell Head and Neck Cancer (Excluding Nasopharynx) Practice Guideline #5-6a Report Date: February 23, 2000 Updated: March 28, 2000 SUMMARY Guideline Question For patients with locally advanced stage III or IV squamous cell head and neck cancer in whom radiotherapy is considered the initial modality of choice for cure, does the addition of concomitant chemotherapy improve survival with acceptable toxicity? Target Population These recommendations apply to patients with newly diagnosed stage III or IV squamous cell cancer of the head and neck who are being considered for radiotherapy as the definitive modality for curative intent, and for whom combined ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored By: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care The Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer Practice Guideline Report #7-13-3 ORIGINAL GUIDELINE: October 8, 1999 RECOMMENDATIONS MODIFIED: January 2003 MOST RECENT LITERATURE SEARCH: December 2002 NEW EVIDENCE ADDED TO GUIDELINE REPORT: January 2003 Based on new evidence that emerged after completion of the original guideline, the Lung Cancer Disease Site Group modified the guideline recommendations in January 2003. The revised recommendations are labelled Update . SUMMARY Guideline Question Is there a role for thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer ? Target Population ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored By: Cancer Care Ontario & Ontario Ministry of Health and Long-Term Care Breast Irradiation in Women with Early Stage Invasive Breast Cancer Following Breast Conserving Surgery Practice Guideline Report #1-2 ORIGINAL GUIDELINE: March 11, 1997 UPDATE: January 2002 The Breast Cancer Disease Site Group is rewriting this practice guideline report. The revised guideline report will incorporate all new evidence that has become available since the guideline was completed in 1997. The new evidence under review is noted below (labelled NEW), and is identified in the update sections of the full report. The current guideline recommendations remain in effect. SUMMARY Guideline Questions • Should breast irradiation be given to women with early stage breast cancer (stage I and II) ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored By: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer Practice Guideline Report #7-12 ORIGINAL GUIDELINE: October 8, 1999 MOST RECENT LITERATURE SEARCH: September 2002 NEW EVIDENCE ADDED TO GUIDELINE REPORT: October 2000 APPENDIX UPDATED: January 2003 New evidence found between completion of the original guideline and October 2000 is consistent with the original recommendations. No new evidence has been found by update searches since October 2000. SUMMARY Guideline Question Do any altered fractionation radiation schemes prolong survival in the treatment of locally advanced, unresectable stage III non-small cell lung cancer (NSCLC) compared ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored by: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care The Role of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (excluding nasopharynx) Practice Guideline Report # 5-1 ORIGINAL GUIDELINE: February 15, 1996 MOST RECENT LITERATURE SEARCH: February 2003 NEW EVIDENCE ADDED TO THE GUIDELINE REPORT: February 2003 New evidence found by update searches since the completion of the original guideline is consistent with the original recommendation. A qualifying statement has been added. SUMMARY Guideline Question What is the role of neoadjuvant chemotherapy in the treatment of patients with locally advanced squamous cell carcinoma of the head and neck region (excluding nasopharynx)? Target Population These ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored by: Cancer Care Ontario & the Ontario Ministry of Health and Long-term Care Management of Ductal Carcinoma In Situ of the Breast Practice Guideline Report #1-10 ORIGINAL GUIDELINE: January 20, 1998 MOST RECENT LITERATURE SEARCH: January 30, 2003 NEW EVIDENCE ADDED TO THE GUIDELINE: December 10, 2002 RECOMMENDATIONS MODIFIED: November, 2002 The Breast Cancer Disease Site Group is rewriting this practice guideline report. The new guideline will include modified recommendations/evidence on the use of tamoxifen in patients with DCIS. Guideline Questions • What is the optimal surgical management of ductal carcinoma in situ (DCIS) of the breast? • Should breast irradiation be offered to women with DCIS following breast conserving surgery (or lumpectomy, defined ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored by: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care Adjuvant Chemotherapy Following Complete Resection of Soft Tissue Sarcoma in Adults Practice Guideline Report #11-2 ORIGINAL GUIDELINE: November 2000 MOST RECENT LITERATURE SEARCH: October 2002 NEW EVIDENCE ADDED TO GUIDELINE REPORT: October 2002 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Questions 1. What are the benefits of anthracycline-based adjuvant chemotherapy in adult patients with completely resected soft tissue sarcomas, in terms of local disease control, systemic recurrence and overall survival? 2. When these benefits are assessed in the context of expected toxicities, in what circumstances should ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored By: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care Unresected Stage Ill Non-Small Cell Lung Cancer Practice Guideline Report #7-3 ORIGINAL GUIDELINE: March 14, 1997 MOST RECENT LITERATURE SEARCH: December 2002 NEW EVIDENCE ADDED TO GUIDELINE REPORT: January 2003 RECOMMENDATIONS LAST MODIFIED: The recommendations have not been modified since the original guideline was developed. The Lung Disease Site Group is rewriting this practice guideline report and may revise the recommendations. The rewritten guideline report will include new evidence on the use of palliative radiotherapy, hyperfractionated radiotherapy, and accelerated radiotherapy in the treatment of unresected stage III disease, as well as evidence on the sequencing of chemotherapy relative to radiotherapy in ...

REVIEW OF NUTRITION INTERVENTIONS FOR CANCER PREVENTION Prepared for Prevention Unit Division of Preventive Oncology Cancer Care Ontario Prepared by Ms. Tina B. Sahay Health Promotion Consulting Group Dr. Irving Rootman Centre for Health Promotion Dr. Fredrick D. Ashbury PICEPS Consultants, Inc. Page 2 ABLE OF CONTENTS EXECUTIVE SUMMARY..i SECTION 1: INTRODUCTION....1 SECTION 2: SELECTION PROCESS Search Strategy.7 Relevance Testing.7 Assessment and Categorization.....8 Figure 1: Assessment and Categorization Scheme...11 Figure 2: Results of Assessment and Categorization12 SECTION 3: REVIEW OF LITERATURE COLLECTED.13 Part I: Best Practices..14 Part II: Promising Practices...33 Part III: Negative Practices45 SECTION 4: SUMMARY OF FINDINGS..50 SECTION 5: RECOMMENDATIONS.55 ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored by: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care Accelerated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Practice Guideline Report # 5-6c ORIGINAL GUIDELINE: November 27, 2000 MOST RECENT LITERATURE SEARCH: October 2002 NEW EVIDENCE ADDED TO GUIDELINE REPORT: October 2002 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Questions Does accelerated radiotherapy improve loco-regional control or survival compared with conventionally fractionated radiotherapy in patients with newly diagnosed, locally advanced (stage III-IV) squamous cell carcinoma of the head and neck who are deemed suitable for radiotherapy with curative intent? What is ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored by: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care Hyperfractionated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Practice Guideline Report #5-6b ORIGINAL GUIDELINE: November 27, 2000 MOST RECENT LITERATURE SEARCH: January 2003 NEW EVIDENCE ADDED TO GUIDELINE REPORT: January 2003 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Questions Does hyperfractionated radiotherapy improve loco-regional control or survival compared with conventionally fractionated radiotherapy in patients with newly diagnosed, locally advanced (stage III-IV) squamous cell carcinoma of the head and neck who are deemed suitable for radiotherapy with ...

Ohio Partners for Cancer Control The Ohio Cancer Plan: 2010 acs_cover_only 4/23/03 1:09 PM Page 2 Page 2 The Ohio Cancer Plan: 2010 – 1 – Ohio Partners for Cancer Control Contents Resolution.02 Introduction.03 Priorities to Advance Comprehensive Cancer Control in Ohio..04 Ten Goals for Comprehensive Cancer Control, 2003-2010..05 Getting Started..06 Aspects of Comprehensive Cancer Control..10 The Cancer Burden in Ohio14 Eliminating Disparities..32 Survivorship.35 Healthy People 2010..36 Summary37 References.40 The Ohio Partners for Cancer Control has as its mission “to make cancer history for all Ohioans.” American Cancer Society, Ohio Division American College of Surgeons, Ohio Chapter Appalachia ...

Antibiotic Resistance and its Impact on Cancer Patients For more than half a century, antibiotic drugs have ensured that potentially life-threatening bacterial infections are treatable. Today, however, more and more bacterial infections fail to respond to antibiotic treatment. A federal task force recently warned that antibiotic resistance is “a growing menace to all people” and concluded that if nothing is done, treatments for common infections will become “increasingly limited and expensive- and, in some cases, nonexistent .” Antibiotic resistance poses a threat to everyone, but cancer patients are at particular risk. Cancer is typically treated with surgery, radiation, chemotherapy, and/or transplantation of bone marrow or blood stem cells. Each of these treatment techniques leaves a patient more vulnerable to infection than is a healthy adult of similar age. A large majority of cancer patients undergo surgery. ...

Cancer in Idaho - 2001 Annual Report of the CancerDataRegistryofIdaho April 2003 25 th Anniversar y Page 2 P. O . B O X 1 2 7 8 BOISE, ID 83701 - 1278 PHONE: 208.338.5100 F A X : 2 0 8 . 3 3 8 . 7 8 0 0 Page 3 A Publication of the Cancer Data Registry of Idaho A Program of the Idaho Hospital Association Editors: Christopher J. Johnson, MPH, Epidemiologist Stacey L. Carson, RHIT, CTR, Vice President and Executive Director/CDRI Contributors: Denise Jozwik, RHIT, CTR, Assistant Director Jessica Shew, CTR, Cancer Data Controller Deanna Schmidt, RHIT, CTR, Cancer Registry Consultant April 2003 CANCER DATA REGISTRY OF IDAHO P.O. Box 1278 Boise, Idaho 83701-1278 208-338-5100 ext ...

3 2 Cellular Health Series: Cancer Matthias Rath, M.D. First Edition, February 2001 Cellular Health Series - Cancer . Copyright 2001 by Matthias Rath, M.D. All rights reserved. Published by MR Publishing, Inc., Santa Clara, CA 95054 No part of this book may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in critical articles or reviews. For information, address: This book is not intended as a substitute for the medical advice of a physician. The reader should regularly consult a physician in matters relating to his or her health and particularly in respect to any symptoms that may require diagnosis or medical attention. The authors and the publisher disclaim responsibility for any adverse effects resulting directly or indirectly from the information contained in this book. ...

Kansas Cancer Control Plan Part I Problem Definition, Burden of Disease, and Health Objectives A Report of the Kansas Cancer Partnership Bureau of Health Promotion Kansas Department of Health and Environment 1000 SW Jackson, Suite 230 Topeka, KS 66612 April 8, 2002 This document attempts to faithfully represent consensus work of the Kansas Cancer Partnership. Consequently, all of the consensus opinions and decisions reported in this document do not necessarily reflect the opinions and decisions of KDHE, which acted as convener and editor. Page 2 Acknowledgments Staff Coordinators Melissa Dinsmore Julia Francisco Report Preparation Ashley Muir Nkolika Obiesie Stephen P. Pickard Participants Don Abdallah Steve Ades Jasjit Ahluwalia Muhammad Amawi ...

U nderstanding Cancer Treatment Fatigue: Fact You Should Know UPMC Cancer Centers work in tandem with the University of Pittsburgh Cancer Institute, the region’s only National Cancer Institute-designated Comprehensive Cancer Center. For information about cancer , call the UPMC Cancer Centers Cancer Information and Referral Service at 1-800-237-4724 or visit our website at www.upmccancercenters.com. UPMC Cancer Centers Information for Patients Pittsburgh, PA, USA www.upmc.com © University of Pittsburgh Medical Center 2003 SYS09869 ASP/JW REV 03/03 Form # 4745-82190-0302 The University of Pitts- burgh Medical Center is an equal opportunity em- ployer. Policy prohibits discrimination or harass- ment on the basis of race, color, religion, national origin, ancestry, sex, age, ...

continued You may experience taste changes while re- ceiving cancer therapy. Food may taste bitter or spoiled, or have no taste at all. You may de- velop a sudden dislike for certain foods. Your sense of taste may return either partially or completely, but it may take up to a year after therapy ends before your sense of taste is normal again. Please ask your nurse to review this informa- tion with you and to answer any questions you may have. Keep your nurse and doctor informed of your concerns about taste changes. A registered dietitian is available to discuss your diet and can suggest ways to improve the taste of foods. Helpful Hints to Manage Taste Changes • Eat small, frequent meals and healthy snacks. • Eat when you are hungry rather than at set mealtimes. Be flexible. • Make mealtime as pleasant as possible. Prepare foods that look and ...

continued U understanding Thoughts and Feelings During Cancer Therapy The diagnosis of cancer affects each person differently. What might be considered a “normal” reaction by one person may not seem normal to another. It is perfectly normal for you to have emotional high and low periods when being treated for cancer . There will be times when you may feel sad, afraid, angry, or lost. At other times, you may feel hopeful, confident, and ready to confront any problem. It is important for you to express your feelings. You may feel the need to cry, pray, scream in private, laugh aloud, sing in the shower, or sit alone and write your thoughts in a journal. It is also important that you share your feel- ings with others, no matter what the feelings are. You may want to: • talk to your spouse, a trusted friend, or a family member • talk with ...

continued R egaining Sexual Confidence After Cancer UPMC Cancer Centers Information for Patients Having cancer can affect every aspect of your life, including your sexuality. Whether your treatment has included surgery, chemo- therapy, radiotherapy, biotherapy, or any combination of the four, you will need to make adjustments in your life as you recover. Remember that talking honestly with your partner is important to maintaining a strong, supportive relationship. Be patient, be cre- ative. Your nurse can provide you with refer- rals to professional counselors experienced in helping patients who have sexual problems following treatment. The pleasure of sexual closeness enhances quality of life and can be adapted, no matter what treatment has been used. Talk with your doctor or nurse about any restrictions you may have. ...

continued Some patients experience a decrease in appe- tite while receiving cancer therapy and for some time following treatment. Remember that this loss of appetite is a temporary side effect of your treatment. Also, the loss of ap- petite you may experience depends on many factors and varies from person to person. Please ask your nurse to review this informa- tion with you and to answer any questions you may have. Keep your nurse and doctor informed of your concerns about your appe- tite and weight. A registered dietitian is available to discuss your diet and can suggest ways to maintain your normal weight. Helpful Hints to Manage Loss of Appetite • Eat small frequent meals and healthy snacks that are high in protein and calories. • Eat during periods of greatest appetite, rather than at set mealtimes. Be flexible. Eat whenever you feel hungry. ...

Innovation, Knowledge Sharing, & Discovery A Quarterly Report of the London Regional Cancer Centre January to March 2003 Volume 2 No 1 A Cancer Care Ontario Centre / Southwest Region Un centre régional de cancérologie de action cancer ontario The LRCC is pleased to again report research and treatment highlights in the clinic and our laboratories. In this issue we cover the three month period ending March 31st, 2003, including a special report on one of the most common (and preventable) cancers affecting patients and their families in Ontario -- lung cancer . The LRCC is a leader in testing new radiation and chemotherapies for this disease, and in developing new methods to "tailor" treatment choices so they best fit the needs of indi- vidual patients. This issue describes some of the forefront London work that will make a difference for patients. Dr. Jim Koropatnick ...

This information is provided to offer guidance on a particular aspect of legislation. It is not to be taken as a statement of law and must not be construed to waive or modify any legal obligation GS 62 PREVENTING SKIN CANCER ASK YOURSELF: 1. How much of your working life is spent outdoors? 2. At what time of the day do you generally work outdoors? 3. Do you have natural shade areas available? 4. How do you currently protect yourself from the sun? WHY IS SKIN CANCER A RISK? Exposure to ultraviolet radiation (UVR) from the sun is the major cause of skin cancers in Australia. Outdoor workers have a high risk of developing skin cancers , as they are continually exposed to ultraviolet radiation. UV exposure from the sun is greatest between 10 am and 2 pm (11 am and 3 pm daylight saving time) because the sun’s rays are more direct. ...

COLORECTAL CANCER SCREENING i Summary SUMMARY Introduction Colorectal cancer (CRC) is one of the leading causes of cancer death in industrialised countries. Québec does not escape this general trend. As part of its mandate, the Comité consultatif sur le cancer , which was set up by the Ministère de la Santé et des Services sociaux du Québec to examine the entire issue of cancer and ways to combat it, has naturally devoted special attention to colorectal cancer , given its extent. In its 1997 report, the committee could not, at that time, recommend the development of systematic screening activities, one of the reasons being the lack of convincing data. However, it did recommend that the Conseil d'évaluation des technologies de la santé du Québec undertake an in-depth examination of the efficacy and efficiency of CRC screening ...